A microtiter assay for activation of eosinophils. Simultaneous monitoring of eosinophil adhesion and degranulation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 2, 1998, Pages 129-138

  Reimert, C M ^a   Skov, P S ^a   Poulsen, L K ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Activation assay; Adhesion; Degranulation; Eosinophil; Eosinophil activation

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN;

ARTICLE; BLOOD SAMPLING; CELL ADHESION; DEGRANULATION; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031827627     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03860.x     Document Type: Article

References (39)

1. Butterworth AE, Sturrock RF, Houba D, Mahmoud AAF, Sher A, Rees PH. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature 1975;256:727-9.
2. David JR, Butterworth AE, Azevedo de Brito P, et al. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med 1980;303:1147-52.
3. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-7.
4. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:20-6.
5. Kimani G, Tonnese MG, Henson PM. Stimulation of eosinophil adherence to vascular endothelial cells in vitro by platelet activating factor. J Immunol 1988;140:3161-6.
6. Walsh GM, Hartnell A, Wardlaw AJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
7. Håkanson L, Carlson M, Stålenheim G, Venge P. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma. J Allergy Clin Immunol 1990;85:743-50.
8. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor: a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-6.
9. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
10. Baskar P, Pinkus SH. Selective regulation of eosinophil degranulation by interleukin 1 beta. Proc Soc Exp Biol Med 1992;199:249-54.
11. Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5, and GM-CSF on normal eosinophil and neutrophil C3b-induced degranulation. Allergy 1993;48:437-42.
12. Fujisawa T, Abu-Ghazelah R, Kita H, Sanderson SJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
13. Winqvist I, Olofson T, Olsson I. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein. Immunology 1984;51:1-8.
14. Sedgwick JB, Vrtis RF, Gourley MF, Busse WW. Stimulusdependent differences in Superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol 1988;81:876-83.
15. Shult PA, Graziano FM, Wallow IH, Busse WW. Comparison of superoxide generation and luminol-dependent chemiluminescence with eosinophils and neutrophils from normal individuals. J Lab Clin Med 1985;106:638-45.
16. Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet activating factor in activated human eosinophils. J Biol Chem 1984;259:5526-30.
17. 4 by human eosinophils. J Immunol 1987;138:532-8.
18. Silberstein DS, Owen WF, Gasson JC, et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol 1986;137:3290-4.
19. Carlson M, Håkanson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
20. Hansel TT, De-Vries IJ, Iff T, et al. An improved immuno-magnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;1-2:105-10.
21. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991;138:285-90.
22. Reimert CM, Minuva U, Kharazmi A, Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN): detection by enzyme-linked immunosorbent assay and purification from normal human urine. J Immunol Methods 1991;141:97-104.
23. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet activating factor. J Immunol 1994; 152:5457-67.
24. Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K. Eosinophil degranulation in the presence of bronchial epithelial cells. J Immunol 1996;156:3980-5.
25. Hartnell A, Moqbel R, Walsh GM, Bradley B, Kay AB. Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 1990;69:264-70.
26. Bach MK, Brashler JR, Sanders ME, Biemkowski MJ. Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils. J Immunol Methods 1991; 142:243-50.
27. 2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1996;155:2631-41.
28. Carlson M, Oberg G, Peterson C, Venge P. Releasability of human hypereosinophilic eosinophils is related to the density of the cells. Br J Haematol 1994;86:41-7.
29. Metcalfe DD, Gadek JE, Raphael GD, Frank MM, Kaplan AP, Kaliner M. Human eosinophil adherence to serum-treated Sepharose: granule-associated enzyme release and requirements of the alternative complement pathway. J Immunol 1977;119:1744-50.
30. Peterson CG, Garcia RC, Carlson MGC, Venge P. Eosinophil cationic protein (ECP), eosinophil protein-X (EPX) and eosinophil peroxidase (EPO): granule distribution, degranulation and characterization of released proteins. In: Peterson CGB, editor. Eosinophil granule proteins. Biochemical and functional studies. Doctoral thesis, Uppsala University, Sweden, 1987:III,1-19.
31. Anderson DC, Miller LJ, Schmalstieg FC, Rothlein R, Springer TA. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessment employing subunit-specific monoclonal antibodies. J Immunol 1986;137:15-27.
32. Carrera AC, Rincon M, Sanchez-Madrid F, Lopez-Botet M, de-Landazuri MO. Triggering of co-mitogenic signals in T-cell proliferation by anti-LFA-1 (CD18, CD11a), LFA3, and CD7 monoclonal antibodies. J Immunol 1988;141:1019-24.
33. Egesten A, Gullberg U, Olsson I, Richter J. Phorbol esterinduced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins. J Leukoc Biol 1993;53:287-93.
34. Natan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989;109:1341-9.
35. Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and Superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:371-81.
36. Håkanson L, Søegaard Nielsen L, Teder P. Measurement of neutrophil and eosinophil adhesion to E-selectin, VCAM-1. and ICAM-1 by the use of transfected fibroblast cell lines. J Immunol Methods 1994;176:53-66.
37. Tai P-C, Spry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309: 182-3.
38. Wardlaw A. Eosinophil density: what does it mean? Clin Exp Allergy 1995;25:1145-9.
39. Kita H, Horie S, Gleich GJ. Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils. J Immunol 1996;156:1174-81.